Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
07 February 2018 Photo ICC
Raynard named captain of the Team of the Tournament at U-19 World Cup
Raynard van Tonder, right, is congratulated by fellow player Hermann Rolfes after scoring his second century against Bangladesh at the U-19 Cricket World Cup in New Zealand.

Raynard van Tonder was rewarded for an outstanding U-19 World Cup in New Zealand when he was named as the captain of the Team of the Tournament, announced by the International Cricket Council on Sunday.

The Kovsie cricketer, who captained the South African team to fifth place, ended with the third-most runs in the tournament; 348 in six matches at an impressive average of 69.6. He scored two centuries (one of three players to achieve this) and one 50. It included a knock of 143 against Kenya, which was the fifth-highest in the tournament. With that, the 19-year-old also recorded the third-highest score ever by a South African in an U-19 One Day International.

Van Tonder is studying a BSocSci at the University of the Free State (UFS).

Congratulations from CSA

“It is heartening to know
that we continue to produce
quality players and leaders.”
—Thabang Moroe
Acting Chief Executive
of Cricket South Africa

“Raynard deserves a special commendation for being chosen as the best leader at the tournament. This follows on our 2014 captain, Aiden Markram (currently leading the Proteas in the one-day series against India), who was chosen as Player of the Tournament back then.

“It is heartening to know that we continue to produce quality players and leaders through our talent pipeline system,” commented acting chief executive of Cricket South Africa (CSA), Thabang Moroe.

The Team of the ICC U-19 Cricket World Cup was selected by a panel that comprised former Windies fast bowler Ian Bishop, former India women’s captain Anjum Chopra, former New Zealand captain Jeff Crowe, journalist Shashank Kishore and former Australia all-rounder Tom Moody.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept